Grifols Stock Forum

Morning traders, it is the final slow week before a new earnings season begins Thurday with   $Delta Air Lines(DAL.US)$ and properly on Friday with   $JPMorgan(JPM.US)$.
Welcome to the end of the dog days of summer for a while; my name is Kevin Travers, and here are stories from the moomoo herd on Wall Street today.
$Intel(INTC.US)$ traded higher after the firm said it had bypassed Vietnam for a $3.3B project and in...

$Grifols(GRFS.US)$ PM high broke

1. $Shapeways(SHPW.US)$
2. $Inspire Veterinary Partners(IVP.US)$
3. $Dynatronics(DYNT.US)$
4. $Zapp Electric Vehicles(ZAPP.US)$
5. $Maxeon Solar Technologies(MAXN.US)$
6. $Grifols(GRFS.US)$
7. $SinglePoint(SING.US)$
8. $Venus Concept(VERO.US)$
9. $IDEAYA Biosciences(IDYA.US)$
10. $Kuke Music(KUKE.US)$

$Grifols(GRFS.US)$ Grifols' founding family and Canadian fund Brookfield are considering a joint takeover bid of the Spanish drugmaker to take it private, after the company shed billions in market value following a variety of accusations from a short-seller.

$Grifols(GRFS.US)$ Grifols Says €1.6 Billion Net Cash Proceeds From Sale Of 20% Equity Stake In Shanghai RAAS Are Currently Deposited In Co's Bank Account; Proceeds Will Be Fully Allocated To Reduce 2025 Senior Secured Notes And 2027 Term Loan B And On A Pro-Rata Basis As Per Credit Agreement; To Repay In Full 2025 Debt Maturities, Leaving No Additional Maturities Until 2027
- Reuters

$Grifols(GRFS.US)$ Grifols' Subsidiary Biotest Receives FDA Approval For Yimmugo, An Intravenous Immunoglobulin Therapeutic, To Treat Primary Immunodeficiencies, With US Launch Expected In Second Part Of 2024
Benzinga· 1 min ago

$Grifols(GRFS.US)$ Notorious Short seller GOTHAM spread FUD and crashes price a few weeks back! And then others keep posting the hit piece! But you hardly see any stories that GRIFOLS has filed a lawsuit against GOTHAM for that accusation! Grrrr! Well here GOTHAM, take this! Not great but good start! At least IMO!                                                                (((((((((.   Grifols Q1 Net Revenues €1.63 Billion Vs €1.56 Billion YoY; Sees Q1 R&D Negative Net Investment €90.5 M...

$Grifols(GRFS.US)$ MT Newswires· 3 mins ago
Grifols (GRF.MC) said Monday that the sale of its 20% stake in blood products company Shanghai RAAS to Chinese home appliance company Haier Group is expected to be completed by June.
The Spanish pharmaceutical company said both the buyer and seller secured the necessary domestic and overseas government approvals for the deal. It noted that the transaction still requires a compliance confirmation from the Shenzhen Stock Exchange.

$Grifols(GRFS.US)$ April 22, 2024 Grifols achieves positive results from phase 4 study of Fanhdi® (double-inactivated human anti-hemophilic factor) in patients with von Willebrand Disease Download PDF Grifols’ Fanhdi showed it could be effective, safe and well tolerated in the management of bleeding episodes and for the prevention of bleeding during surgeries in patients with von Willebrand Disease (VWD) VWD, which is caused by a deficiency of von Willebrand factor in plasma, is the most common ...

$Grifols(GRFS.US)$ Grifols (GRF.MC) is set to launch a private offering of 1 billion euros of 7.5% senior secured notes due April 2030 for the redemption of senior unsecured notes due May 2025.
The Spanish pharmaceutical group said Tuesday the note offering is contingent upon the fulfillment of customary closing conditions.